Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Richard R. Bergstrom"'
Autor:
Charles M. Beasley, Richard R. Bergstrom, Michael Blumenfield, Richard J. Solomon, Norman B. Levy, Anjani Dubey, Alvin I. Goodman, Robert Todd
Publikováno v:
General Hospital Psychiatry. 18:8-13
Nine depressed patients with normal kidney function and seven depressed patients with renal failure undergoing hemodialysis were treated with open-label fluoxetine 20 mg/day in an 8-week study. The study was designed to evaluate the pharmacokinetics
Autor:
Nguyen Q; Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada., Meng E; Division of Anesthesiology & Pain Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, T6G 2S2, Canada., Berube J; Division of Anesthesiology & Pain Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, T6G 2S2, Canada., Bergstrom R; Division of Anesthesiology & Pain Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, T6G 2S2, Canada., Lam W; Division of Anesthesiology & Pain Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, T6G 2S2, Canada. wingying@ualberta.ca.
Publikováno v:
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2021 Apr 23; Vol. 16 (1), pp. 109. Date of Electronic Publication: 2021 Apr 23.
Autor:
Schulthess D; 1 Vital Transformation, Wezembeek-Oppem, Belgium., Baird LG; 2 MIT, Center for BioMedical Innovation, Cambridge, MA, USA., Trusheim M; 3 MIT Sloan School of Management, Cambridge, MA, USA., Unger TF; 4 MIT, Regulatory Strategy, Cambridge, MA, USA.; 5 Naia Pharma, Cayman Islands., Lumpkin M; 6 Bill and Melinda Gates Foundation, Seattle, WA, USA., Hoos A; 7 AMGEN, Medical for Europe, Zug, Switzerland., Garner S; 8 National Institute for Health and Clinical Excellence, Research and Development, London, England., Gavin P; 9 NORD, Quincy, MA, USA., Goldman M; 10 Institute for Interdisciplinary Innovation in Healthcare, Université Libre de Bruxelles, Brussels, Belgium., Seigneuret N; 11 Innovative Medicines Initiative, Brussels, Belgium., Chlebus M; 12 EFPIA, Brussels, Belgium., Van Baelen K; 13 Janssen Pharmaceuticals, Antwerp, Belgium., Bergstrom R; 12 EFPIA, Brussels, Belgium., Hirsch G; 2 MIT, Center for BioMedical Innovation, Cambridge, MA, USA.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2016 May; Vol. 50 (3), pp. 347-354.
Autor:
Mitchell M; Lilly Research Laboratories, Indianapolis, Indiana. Electronic address: mim@lilly.com., Kothare P; Lilly Research Laboratories, Indianapolis, Indiana., Bergstrom R; Indiana University School of Medicine, Indianapolis, Indiana., Zhao F; Lilly Research Laboratories, Indianapolis, Indiana., Jen KY; PharmaNet/i3, Indianapolis, Indiana., Walker D; Lilly Research Laboratories, Indianapolis, Indiana., Johnson J; Lilly Research Laboratories, Indianapolis, Indiana., McDonnell D; Lilly Research Laboratories, Indianapolis, Indiana.
Publikováno v:
Clinical therapeutics [Clin Ther] 2013 Dec; Vol. 35 (12), pp. 1890-908. Date of Electronic Publication: 2013 Oct 31.
Autor:
Laxminarayan R; Center for Disease Dynamics, Economics and Policy, Washington, DC, USA; Princeton University, Princeton NJ, USA; Public Health Foundation of India, New Delhi, India., Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C, So AD, Bigdeli M, Tomson G, Woodhouse W, Ombaka E, Peralta AQ, Qamar FN, Mir F, Kariuki S, Bhutta ZA, Coates A, Bergstrom R, Wright GD, Brown ED, Cars O
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2013 Dec; Vol. 13 (12), pp. 1057-98. Date of Electronic Publication: 2013 Nov 17.
Autor:
Bergstrom R Jr; Department of Materials Science and Engineering, University of Maryland, College Park, Maryland 20742, USA., Wuttig M, Cullen J, Zavalij P, Briber R, Dennis C, Garlea VO, Laver M
Publikováno v:
Physical review letters [Phys Rev Lett] 2013 Jul 05; Vol. 111 (1), pp. 017203. Date of Electronic Publication: 2013 Jul 03.
Autor:
Bergstrom R; EFPIA - European Federation of Pharmaceutical Industries and Associations, Brussels, Belgium. richardbergstrom@efpia.org
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2012 Jan; Vol. 13 (1), pp. 14-5.
Autor:
Knadler MP; Eli Lilly and Company, Indianapolis, Indiana 46285, USA. Knadler_Mary_Pat@lilly.com, Lobo E, Chappell J, Bergstrom R
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2011 May; Vol. 50 (5), pp. 281-94.
Autor:
Tohen M; Lilly Research Laboratories, Indianapolis, Indiana 46285, USA. m.tohen@lilly.com, Bowden CL, Smulevich AB, Bergstrom R, Quinlan T, Osuntokun O, Wang WV, Oliff HS, Martenyi F, Kryzhanovskaya LA, Greil W
Publikováno v:
The British journal of psychiatry : the journal of mental science [Br J Psychiatry] 2008 Feb; Vol. 192 (2), pp. 135-43.
Autor:
Ashley T; Gen Re LifeHealth, 695 E Main St, Stamford, CT 06901, USA. tashley@genre.com, Titcomb CP Jr, Hart A, Bergstrom R
Publikováno v:
Journal of insurance medicine (New York, N.Y.) [J Insur Med] 2008; Vol. 40 (2), pp. 110-5.